| 1. |
Vassallo P, Trohman RG. Prescribing amiodarone: an evidence-based review of clinical indications[J]. JAMA, 2007, 298(11): 1312-1322. DOI: 10.1001/jama.298.11.1312.
|
| 2. |
Costa-Jussà FR, Jacobs JM. The pathology of amiodarone neurotoxicity. I. experimental studies with reference to changes in other tissues[J]. Brain, 1985, 108 (Pt 3): 735-752. DOI: 10.1093/brain/108.3.735.
|
| 3. |
Mansour AM, Puklin JE, O'Grady R. Optic nerve ultrastructure following amiodarone therapy[J]. J Clin Neuroophthalmol, 1988, 8(4): 231-237.
|
| 4. |
Chen D, Hedges TR. Amiodarone optic neuropathy--review[J]. Semin Ophthalmol, 2003, 18(4): 169-173. DOI: 10.1080/08820530390895163.
|
| 5. |
Rogers NK, Bowen DI, Noble BA. Development of atypical amiodarone keratopathy in a corneal graft[J]. Eye (Lond), 1993, 7 (Pt 4): 594-596. DOI: 10.1038/eye.1993.129.
|
| 6. |
Johnson LN, Krohel GB, Thomas ER. The clinical spectrum of amiodarone-associated optic neuropathy[J]. J Natl Med Assoc, 2004, 96(11): 1477-1491.
|
| 7. |
Rucker JC, Biousse V, Newman NJ. Ischemic optic neuropathies[J]. Curr Opin Neurol, 2004, 17(1): 27-35. DOI: 10.1097/00019052-200402000-00006.
|
| 8. |
Macaluso DC, Shults WT, Fraunfelder FT. Features of amiodarone-induced optic neuropathy[J]. Am J Ophthalmol, 1999, 127(5): 610-612. DOI: 10.1016/s0002-9394(99)00016-1.
|
| 9. |
Passman RS, Bennett CL, Purpura JM, et al. Amiodarone-associated optic neuropathy: a critical review[J]. Am J Med, 2012, 125(5): 447-453. DOI: 10.1016/j.amjmed.2011.09.020.
|
| 10. |
Purvin V, Kawasaki A, Borruat FX. Optic neuropathy in patients using amiodarone[J]. Arch Ophthalmol, 2006, 124(5): 696-701. DOI: 10.1001/archopht.124.5.696.
|
| 11. |
Luneau K, Newman NJ, Biousse V. Ischemic optic neuropathies[J]. Neurologist, 2008, 14(6): 341-354. DOI: 10.1097/NRL.0b013e 318177394b.
|
1/5
WeChat